Peregrine Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.75M	Buy	486,641 +34,139	+8%	+$544K	0.25%	120
2025 Q4	$7.35M	Sell	452,502 -70,300	-13%	-$1.15M	0.23%	127
2025 Q3	$7.82M	Sell	522,802 -179,909	-26%	-$2.19M	0.24%	118
2025 Q2	$8.19M	Buy	+702,711	New	+$6.38M	0.25%	110
2024 Q2	–	Sell	-375,716	Closed	-$1.21M	–	326
2024 Q1	$1.21M	Buy	375,716 +78	+0%	+$302	0.03%	264
2023 Q4	$1.84M	Sell	375,638 -64,317	-15%	-$293K	0.06%	245
2023 Q3	$2.4M	Sell	439,955 -27,331	-6%	-$181K	0.07%	247
2023 Q2	$3.14M	Sell	467,286 -109	-0%	-$810	0.09%	247
2023 Q1	$4.13M	Buy	467,395 +199,764	+75%	+$1.76M	0.12%	243
2022 Q4	$2.04M	Sell	267,631 -11,100	-4%	-$86.4K	0.06%	241
2022 Q3	$1.99M	Sell	278,731 -15,222	-5%	-$143K	0.06%	245
2022 Q2	$2.38M	Sell	293,953 -24,192	-8%	-$213K	0.07%	252
2022 Q1	$4.42M	Sell	318,145 -21,316	-6%	-$335K	0.1%	248
2021 Q4	$9.53M	Buy	339,461 +62,118	+22%	+$1.9M	0.19%	209
2021 Q3	$9.43M	Sell	277,343 -44,578	-14%	-$1.61M	0.2%	218
2021 Q2	$13.2M	Buy	321,921 +37,628	+13%	+$1.46M	0.24%	200
2021 Q1	$11.4M	Sell	284,293 -12,513	-4%	-$677K	0.21%	223
2020 Q4	$17.6M	Sell	296,806 -30,424	-9%	-$1.57M	0.33%	108
2020 Q3	$15.9M	Sell	327,230 -45,817	-12%	-$1.93M	0.42%	89
2020 Q2	$18M	Sell	373,047 -12,543	-3%	-$457K	0.51%	68
2020 Q1	$10.7M	Buy	385,590 +90,041	+30%	+$2.51M	0.38%	109
2019 Q4	$8.84M	Buy	+295,549	New	+$8.49M	0.23%	158